aod9604 clinical studies AOD-9604 Peptide (≥98% Purity) – Research Compound AOD-9604 Best Research Peptide 98%+

ISBN 978-0-387-78518-9

Nicotinamide N-methyltransferase (NNMT) is a key enzyme located in the cytosolic milieu that catalyzes the transfer of methyl group from the co-factor S-(5-Adenosyl)-L-methionine (SAM) to substrates such as nicotinamide (NCA), pyridine, and related analogs, such as quinoline, isoquinoline, and the1,2,3,4 tetrahydroisoquinoline.aliphatic amine NNMT directly regulates the detoxification of endogenous and exogenous drugs/xenobiotics by the formation of methylated metabolic products, such as 1-methyl nicotinamide (1-MNA), methylated pyridiniums, and methylated related analogs

However, elevated levels may indicate underlying conditions such as liver disease, haematological disorders, or kidney impairment that require medical investigation and management

Understanding recommended practices ensures optimal benefit whilst minimising unnecessary risks

When prescribed and monitored appropriately, peptide therapies are generally well tolerated

Each prescription is produced to ensure consistent potency, purity, and reliability with every dose